Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

The American Urological Association Symptom Index For Benign Prostatic Hyperplasia. The Measurement Committee Of The American Urological Association.

M. Barry, F. Fowler, M. O'Leary, R. Bruskewitz, H. L. Holtgrewe, W. K. Mebust, A. T. Cockett
Published 1992 · Medicine

Save to my Library
Download PDF
Analyze on Scholarcy
Share
A symptom index for benign prostatic hyperplasia (BPH) was developed and validated by a multidisciplinary measurement committee of the American Urological Association (AUA). Validation studies were conducted involving a total of 210 BPH patients and 108 control subjects. The final AUA symptom index includes 7 questions covering frequency, nocturia, weak urinary stream, hesitancy, intermittence, incomplete emptying and urgency. On revalidation, the index was internally consistent (Cronbach's alpha = 0.86) and the score generated had excellent test-retest reliability (r = 0.92). Scores were highly correlated with subjects' global ratings of the magnitude of their urinary problem (r = 0.65 to 0.72) and powerfully discriminated between BPH and control subjects (receiver operating characteristic area 0.85). Finally, the index was sensitive to change, with preoperative scores decreasing from a mean of 17.6 to 7.1 by 4 weeks after prostatectomy (p < 0.001). The AUA symptom index is clinically sensible, reliable, valid and responsive. It is practical for use in practice and for inclusion in research protocols.
This paper references



This paper is referenced by
10.1016/j.juro.2011.04.058
Urinating in the standing position: a feasible alternative for elderly women with knee osteoarthritis.
E. Chou (2011)
10.1111/j.1532-5415.2011.03724.x
Behavioral Versus Drug Treatment for Overactive Bladder in Men: The Male Overactive Bladder Treatment in Veterans (MOTIVE) Trial
K. Burgio (2011)
10.1016/j.clon.2012.10.012
The effect of high dose rate brachytherapy in combination with external beam radiotherapy on men's health-related quality of life and sexual function over a 2 year time span.
H.M. Conaglen (2013)
10.1158/1078-0432.CCR-08-3357
Sequence Variant Discovery in DNA Repair Genes from Radiosensitive and Radiotolerant Prostate Brachytherapy Patients
T. Pugh (2009)
10.1016/j.urolonc.2011.02.002
Pretreatment depressive symptoms and treatment modality predict post-treatment disease-specific quality of life among patients with localized prostate cancer.
N. Mohamed (2012)
10.1016/j.juro.2012.08.008
Risks of nocturia in patients with chronic kidney disease--do the metabolic syndrome and its components matter?
M. Wu (2012)
10.1016/j.juro.2012.02.036
Use of validated bladder/bowel dysfunction questionnaire in the clinical pediatric urology setting.
Beth A. Drzewiecki (2012)
10.1016/j.urology.2010.02.051
No long-term effects of hormonal therapy preceding brachytherapy on urinary function and health-related quality of life among prostate cancer patients.
J. Evers (2010)
10.1016/j.urology.2008.02.025
Urinary quality of life after prostatectomy or radiation for localized prostate cancer: a prospective longitudinal cross-cultural study between Japanese and U.S. men.
S. Namiki (2008)
10.1016/j.urology.2007.11.033
Diagnostic and predictive value of voiding diary data versus prostate volume, maximal free urinary flow rate, and Abrams-Griffiths number in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia.
G. E. van Venrooij (2008)
Reproductive ecology and life history of human males: a migrant study of Bangladeshi men
K. Magid (2011)
10.1016/J.IJROBP.2005.07.970
Dosimetry and preliminary acute toxicity in the first 100 men treated for prostate cancer on a randomized hypofractionation dose escalation trial.
A. Pollack (2006)
Surgery and me : the experience of surgery as a transition in young adults with inflammatory bowel disease
M. Allison (2015)
10.1185/030079908X280473
Nocturia in Spanish patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH)
C. Hernández (2008)
10.1016/J.UROLONC.2004.12.014
Associations between polymorphisms in the steroid 5-alpha reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancer.
M. Salam (2005)
10.1097/DCR.0000000000000862
Quality of Life in Rectal Cancer Patients After Chemoradiation: Watch-and-Wait Policy Versus Standard Resection – A Matched-Controlled Study
B. Hupkens (2017)
10.1007/978-3-030-23277-1
Urological Care for Patients with Progressive Neurological Conditions
J. Stoffel (2019)
10.1007/s00464-010-1089-8
Laparoscopic versus laparotomic radical en bloc hysterectomy and colorectal resection for endometriosis
E. Daraï (2010)
10.1111/j.1442-2042.2010.02518.x
Clinical effect of naftopidil on the quality of life of patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: A prospective study
A. Komiya (2010)
10.1097/01.JU.0000054657.59200.97
A randomized controlled trial comparing transurethral resection of the prostate, contact laser prostatectomy and electrovaporization in men with benign prostatic hyperplasia: analysis of subjective changes, morbidity and mortality.
H. V. van Melick (2003)
10.5489/CUAJ.10124
2010 Update: Guidelines for the management of benign prostatic hyperplasia.
J. Nickel (2010)
10.1111/j.1464-410X.2006.05887.x
Severity categories of the International Prostate Symptom Score before, and urinary morbidity after, permanent prostate brachytherapy
S. Gutman (2006)
10.1016/S0090-4295(01)01506-0
Quality-of-life impact of lower urinary tract symptom severity: results from the Health Professionals Follow-up Study.
G. Welch (2002)
10.1016/S0924-977X(02)00040-8
Painful ejaculation and urinary hesitancy in association with antidepressant therapy: relief with tamsulosin
K. Demyttenaere (2002)
10.1007/3-540-27449-9_12
Surgical results of total mesorectal excision for rectal cancer in a specialised colorectal unit.
K. Ho (2005)
10.1016/S0210-4806(10)70007-3
Criterios de derivación en hiperplasia benigna de próstata para atención primaria
J. Fernández (2010)
10.1016/S0022-5347(01)61950-5
A randomized double-blind trial of oral L-arginine for treatment of interstitial cystitis.
G. E. Korting (1999)
10.1089/end.2014.0767
Robot-Assisted Radical Prostatectomy in Patients with a History of Holmium Laser Enucleation of the Prostate: Feasibility and Evaluation of Initial Outcomes.
Paul T. Gellhaus (2015)
10.19080/JOJUN.2015.01.555598
Comparison of Volumetric Values of Transabdominal and Transrectal Ecosonography with Regard to Postoperative Prostatic Weight in Hyperplasia
J. Villalobos (2017)
10.1016/0149-2918(95)80073-5
Efficacy, tolerability, and effect on health-related quality of life of finasteride versus placebo in men with symptomatic benign prostatic hyperplasia: a community based study. CUSP Investigators. Community based study of Proscar.
C. A. Byrnes (1995)
10.1016/S0022-5347(01)67687-0
Reasons for the weak correlation between prostate volume and urethral resistance parameters in patients with prostatism.
J. R. Bosch (1995)
10.1016/S0149-2918(98)80038-6
Effects of doxazosin in patients with mild, intermediate, and severe benign prostatic hyperplasia.
D. Mobley (1998)
See more
Semantic Scholar Logo Some data provided by SemanticScholar